Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Vold Vision PLLC

Neither a doctor nor a teaching hospital

Research payments

$978,370

200 payments

Through program year 2024, Vold Vision PLLC is reported as receiving $978,370 in research payments, across 200 payments.

By program year

6 rows
Year Kind Amount Payments
2024 Research $94,243 103
2023 Research $295,977 28
2022 Research $190,554 12
2021 Research $95,729 9
2020 Research $113,728 21
2019 Research $188,139 27

Breakdown

Who paid Research payments · program years 2019–2024
  1. RxSight Inc $342,155 113 payments
  2. Alcon Research LLC $230,273 12 payments
  3. Allergan Inc. $158,397 33 payments
  4. AbbVie, Inc. $104,121 21 payments
  5. Carl Zeiss Meditec Production LLC $58,080 4 payments
  6. Bausch Health US, LLC $49,119 7 payments
  7. Ivantis, Inc $36,225 10 payments
Studies the money was for Research payments · program years 2019–2024
  1. RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $214,015 12 payments
  2. Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma $101,075 20 payments
  3. Visual Outcomes and Patient Satisfaction in Subjects with Stable Open-angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery and IOL Implantation with an Extended-depth-of-focus IOL $94,035 3 payments
  4. Visual Performance of a Trifocal IOL in Patients with Mild Open-Angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery $81,493 2 payments
  5. RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $67,380 93 payments
  6. XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS $62,462 11 payments
  7. XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) $62,300 8 payments
  8. RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $60,760 8 payments
  9. A Multi-Center, Prospective Clinical Evalutation of the Safety and Effectiveness of the CT Lucia 611P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal. $58,080 4 payments
  10. A Study to Document the Safety and Effectiveness of A New Cohesive Ovd When Compared to A Control Ovd $32,763 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record